Notice for pimicotinib (as hydrochloride hydrate) (Merck Healthcare Pty Ltd)
Active ingredients
pimicotinib (as hydrochloride hydrate)
Sponsor
Date of review outcome
Lapse date
Type
Priority review
Indication
For the treatment of adult patients with symptomatic tenosynovial giant cell tumour (TCGT) who are candidates for systemic therapy
Therapeutic area
Oncology